Nephron 2020 Jan 31
Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol.
Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ
The impact of pretransplant donor-specific antibodies (DSAs), especially class II DSAs, on kidney allograft outcomes remains unclear in simultaneous l ...
Read More
Source: PubMed
J. Clin. Virol.
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation.
Jordan AE, Perlman DC, Cleland CM, Wyka K, Schackman BR, Nash D
Hepatitis C virus (HCV) infection is the most prevalent blood-borne infection and causes more deaths than any other infectious disease in the US. Inci ...
Read More
Source: PubMed
J Racial Ethn Health Disparities 2020 Jan 31
Exploring Awareness of HCV Among Sexual-Minority Black Generation Millennials and Gen Z: a Qualitative Study.
D'Anna L, Washington TA, Cabudol M, Canjura C, Owens J
Hepatitis C (HCV) is a significant public health burden globally. While HIV-positive men who have sex with men (MSM) have traditionally comprised the ...
Read More
Source: PubMed
Virol. J.
Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection.
Liu L, Zhang M, Hang L, Kong F, Yan H, Zhang Y, Feng X, Gao Y, Wang C, Ma H, Liu X, Zhan M, Pan Y, Xu H, Niu J
Hepatitis C virus (HCV) infection is a public health issue for which an effective universal screening method is urgently needed. An oral anti-HCV test ...
Read More
Source: PubMed
Atherosclerosis
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
Adinolfi LE, Petta S, Fracanzani AL, Coppola C, Narciso V, Nevola R, Rinaldi L, Calvaruso V, Staiano L, Di Marco V, Marrone A, Pafundi PC, Solano A, Lombardi R, Sasso FC, Saturnino M, Rini F, Guerrera B, Troina G, Giordano M, Craxì A
HCV is associated with an increased risk of cardiovascular events (CV). Whether HCV clearance by direct-acting antivirals (DAA) reduces incident CV di ...
Read More
Source: PubMed
